Genomics analysis studies have shown median gene upregulation of IL-4, IL-5, and IL-13 mRNA in patients with severe asthma and who expressed the features of type 2 inflammatory asthma (Peters, et al., 2019). The gene discussed is IL13; the disease is asthma.